Anti-DZIP3 antibody
-
概述
- 产品描述E3 Ubiquitin ligase proteins mediate ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Able to specifically bind RNA. pathway:Protein modification; protein ubiquitination. sequence caution:Contaminating sequence. Potential poly-A sequence. Contains 1 RING-type zinc finger. subunit:Interacts with DAZ proteins. tissue specificity:Widely expressed at low level. Highly expressed in skeletal muscle, kidney and heart. Expressed at low level in placenta, lung, brain, liver and pancreas.
- 产品名称Anti-DZIP3 antibody
- 分子量140 kDa
- 种属反应性Human
- 验证应用WB,IHC-P
- 抗体类型兔多抗
- 免疫原The antiserum was produced against synthesized peptide derived from human DZIP3. AA range:681-730
- 偶联Non-conjugated
-
性能
- 形态Liquid
- 浓度1 mg/mL.
- 存放说明Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
- 存储缓冲液Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 亚型IgG
- 纯化方式Immunogen affinity purified.
- 其它名称DZIP3 antibody; KIAA0675 antibody; E3 ubiquitin-protein ligase DZIP3 antibody; DAZ-interacting protein 3 antibody; RNA-binding ubiquitin ligase of 138 kDa antibody; hRUL138 antibody;
-
应用
WB: 1:500-1:2000
IHC-P: 1:100-1:300
特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
